aprepitant

North America

Canada (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EMEND 125MG caps
Rx
oral
A04AD12
EMEND 80MG caps
Rx
oral
A04AD12
EMEND TRI-PACK (125MG+80MG) kit, caps
Rx
oral
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EMEND 125MG caps
02298805
EMEND 80MG caps
02298791
EMEND TRI-PACK (125MG+80MG) kit, caps
02298813
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (34)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
0 powd
Y
Rx
iv
A04AD12
APREPITANT 125MG caps
Y
Rx
oral
A04AD12
APREPITANT 125MG caps
Y
Rx
oral
A04AD12
APREPITANT 125MG caps
Y
Rx
oral
A04AD12
APREPITANT 40MG caps
Y
Rx
oral
A04AD12
APREPITANT 40MG caps
Y
Rx
oral
A04AD12
APREPITANT 40MG caps
Y
Rx
oral
A04AD12
APREPITANT 80MG caps
Y
Rx
oral
A04AD12
APREPITANT 80MG caps
Y
Rx
oral
A04AD12
APREPITANT 80MG caps
Y
Rx
oral
A04AD12
CINVANTI 130MG/18ML (7.2MG/ML) emul
Y
Rx
iv
A04AD12
EMEND caps
N
oral
A04AD12
EMEND powd
N
iv
A04AD12
EMEND 125MG caps
Y
Rx
oral
A04AD12
EMEND 125MG/KIT FOR SUSPENSION
Y
Rx
oral
A04AD12
EMEND 80MG caps
Y
Rx
oral
A04AD12
EMEND EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 115MG BASE/VIAL powd
N
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
Y
Rx
iv
A04AD12
FOSAPREPITANT DIMEGLUMINE UNKNOWN -
Y
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
0 powd
212143/1
ANDA
03-03-2021
APREPITANT 125MG caps
207777/3
ANDA
12-10-2017
APREPITANT 125MG caps
90999/3
ANDA
24-09-2012
APREPITANT 125MG caps
211835/3
ANDA
21-10-2020
APREPITANT 40MG caps
207777/1
ANDA
12-10-2017
APREPITANT 40MG caps
90999/1
ANDA
24-09-2012
APREPITANT 40MG caps
211835/1
ANDA
21-10-2020
APREPITANT 80MG caps
207777/2
ANDA
12-10-2017
APREPITANT 80MG caps
90999/2
ANDA
24-09-2012
APREPITANT 80MG caps
211835/2
ANDA
21-10-2020
CINVANTI 130MG/18ML (7.2MG/ML) emul
209296/1
NDA
09-11-2017
EMEND caps
21549/3
NDA
30-06-2006
EMEND powd
22023/1
NDA
25-01-2008
EMEND 125MG caps
21549/2
NDA
26-03-2003
EMEND 125MG/KIT FOR SUSPENSION
207865/1
NDA
17-12-2015
EMEND 80MG caps
21549/1
NDA
26-03-2003
EMEND EQ 150MG BASE/VIAL powd
22023/2
NDA
12-11-2010
FOSAPREPITANT DIMEGLUMINE EQ 115MG BASE/VIAL powd
204015/1
ANDA
05-09-2019
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
204025/1
ANDA
26-08-2020
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
205020/1
ANDA
05-09-2019
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
210625/1
ANDA
12-01-2021
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
211860/1
ANDA
05-09-2019
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
212309/1
ANDA
05-09-2019
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
211160/1
ANDA
09-12-2020
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
206197/1
ANDA
09-06-2016
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
210689/1
ANDA
05-09-2019
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
209965/1
ANDA
05-09-2019
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
204015/2
ANDA
05-09-2019
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
212957/2
ANDA
20-08-2020
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
213106/1
ANDA
08-09-2020
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
203939/1
ANDA
08-12-2020
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
211624/1
ANDA
05-09-2019
FOSAPREPITANT DIMEGLUMINE EQ 150MG BASE/VIAL powd
210064/1
NDA
05-09-2019
FOSAPREPITANT DIMEGLUMINE UNKNOWN -
204845/1
ANDA
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (20)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT ACCORD 125 MG caps, hard
Rx
-
A04AD12
APREPITANT ACCORD 80 MG caps, hard
Rx
-
A04AD12
APREPITANT ACCORD 80 MG + 125 MG caps, hard
Rx
-
A04AD12
APREPITANT RATIOPHARM 125 MG caps, hard
Rx
-
A04AD12
APREPITANT RATIOPHARM 80 MG caps, hard
Rx
-
A04AD12
APREPITANT RATIOPHARM 80 MG/125 MG caps, hard
Rx
-
A04AD12
APREPITANT SANDOZ 125 MG – caps, hard
Rx
-
A04AD12
APREPITANT SANDOZ 80 MG – caps, hard
Rx
-
A04AD12
APREPITANT SANDOZ 80 MG + 125 MG – caps, hard
Rx
-
A04AD12
ATANTO 125 MG caps, hard
Rx
-
A04AD12
ATANTO 125 MG/80 MG caps, hard
Rx
-
A04AD12
ATANTO 80 MG caps, hard
Rx
-
A04AD12
EMEND 125 MG caps, hard
Rx
-
A04AD12
EMEND 125 MG powd for oral susp
Rx
-
A04AD12
EMEND 125 MG + 80 MG caps, hard
Rx
-
A04AD12
EMEND 165 MG caps, hard
Rx
-
A04AD12
EMEND 40 MG caps, hard
Rx
-
A04AD12
EMEND 80 MG caps, hard
Rx
-
A04AD12
FOSAPREPITANT ACCORD 150 MG powd for sol for inf
Rx
-
A04AD12
IVEMEND 150 MG powd for sol for inf
Rx
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT ACCORD 125 MG caps, hard
138840
29-03-2019
APREPITANT ACCORD 80 MG caps, hard
138842
29-03-2019
APREPITANT ACCORD 80 MG + 125 MG caps, hard
138857
08-04-2019
APREPITANT RATIOPHARM 125 MG caps, hard
138518
17-10-2018
APREPITANT RATIOPHARM 80 MG caps, hard
138517
17-10-2018
APREPITANT RATIOPHARM 80 MG/125 MG caps, hard
138519
17-10-2018
APREPITANT SANDOZ 125 MG – caps, hard
138077
13-12-2017
APREPITANT SANDOZ 80 MG – caps, hard
138076
13-12-2017
APREPITANT SANDOZ 80 MG + 125 MG – caps, hard
138078
13-12-2017
ATANTO 125 MG caps, hard
138713
18-02-2019
ATANTO 125 MG/80 MG caps, hard
138714
19-02-2019
ATANTO 80 MG caps, hard
138712
18-02-2019
EMEND 125 MG caps, hard
EU/1/03/262/004-005
11-11-2003
EMEND 125 MG powd for oral susp
EU/1/03/262/011
16-12-2015
EMEND 125 MG + 80 MG caps, hard
EU/1/03/262/006
11-11-2003
EMEND 165 MG caps, hard
EU/1/03/262/009-010
16-12-2015
EMEND 40 MG caps, hard
EU/1/03/262/007-008
29-05-2006
EMEND 80 MG caps, hard
EU/1/03/262/001-003
11-11-2003
FOSAPREPITANT ACCORD 150 MG powd for sol for inf
138169
09-02-2018
IVEMEND 150 MG powd for sol for inf
EU/1/07/437/003-004
31-08-2010
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Belgium (13)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT SANDOZ 125 MG + 80 MG caps, hard
1x, 125 mg, 2x, 80 mg
Y
oral
A04AD12
APREPITANT TEVA 125 MG + 80 MG caps, hard
125 mg, 80 mg
Y
oral
A04AD12
ATANTO 125 MG caps, hard
1x
5x
-
-

oral
A04AD12
ATANTO 125 MG + 80 MG caps, hard
1x, 125 mg, 2x, 80 mg
-
oral
A04AD12
ATANTO 80 MG caps, hard
1x
2x
5x
-
-
-


oral
A04AD12
EMEND 125 MG caps, hard
1x
1x
-
-

oral
A04AD12
EMEND 125 MG powd for oral susp
1x
Y
oral
A04AD12
EMEND 125 MG + 80 MG caps, hard
1x, 125 mg, 2x, 80 mg
Y
oral
A04AD12
EMEND 165 MG caps, hard
1x
1x
-
-

oral
A04AD12
EMEND 40 MG caps, hard
1x
1x
-
-

oral
A04AD12
EMEND 80 MG caps, hard
1x
1x
2x
-
-
-


oral
A04AD12
IVEMEND 115 MG powd for sol for inf
115 mg
115 mg
-
-

iv
A04AD12
IVEMEND 150 MG powd for sol for inf
150 mg
150 mg
-
Y

iv
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT SANDOZ 125 MG + 80 MG caps, hard
1x, 125 mg, 2x, 80 mg
BE536275
-
APREPITANT TEVA 125 MG + 80 MG caps, hard
125 mg, 80 mg
BE532222
-
ATANTO 125 MG caps, hard
1x
5x
BE538666
BE538666
-
-
ATANTO 125 MG + 80 MG caps, hard
1x, 125 mg, 2x, 80 mg
BE538737
-
ATANTO 80 MG caps, hard
1x
2x
5x
BE538631
BE538631
BE538631
-
-
-
EMEND 125 MG caps, hard
1x
1x
EU/1/03/262/005
EU/1/03/262/004
CP
CP
EMEND 125 MG powd for oral susp
1x
EU/1/03/262/011
CP
EMEND 125 MG + 80 MG caps, hard
1x, 125 mg, 2x, 80 mg
EU/1/03/262/006
CP
EMEND 165 MG caps, hard
1x
1x
EU/1/03/262/010
EU/1/03/262/009
CP
CP
EMEND 40 MG caps, hard
1x
1x
EU/1/03/262/008
EU/1/03/262/007
CP
CP
EMEND 80 MG caps, hard
1x
1x
2x
EU/1/03/262/003
EU/1/03/262/002
EU/1/03/262/002
CP
CP
CP
IVEMEND 115 MG powd for sol for inf
115 mg
115 mg
EU/1/07/437/001
EU/1/07/437/002
CP
CP
IVEMEND 150 MG powd for sol for inf
150 mg
150 mg
EU/1/07/437/004
EU/1/07/437/003
CP
CP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
APREPITANT SANDOZ 125 MG + 80 MG caps, hard
1x, 125 mg, 2x, 80 mg
23,47
APREPITANT TEVA 125 MG + 80 MG caps, hard
125 mg, 80 mg
23,47
ATANTO 125 MG caps, hard
1x
5x
ATANTO 125 MG + 80 MG caps, hard
1x, 125 mg, 2x, 80 mg
ATANTO 80 MG caps, hard
1x
2x
5x
EMEND 125 MG caps, hard
1x
1x
EMEND 125 MG powd for oral susp
1x
8,03
EMEND 125 MG + 80 MG caps, hard
1x, 125 mg, 2x, 80 mg
24,06
EMEND 165 MG caps, hard
1x
1x
EMEND 40 MG caps, hard
1x
1x
EMEND 80 MG caps, hard
1x
1x
2x
IVEMEND 115 MG powd for sol for inf
115 mg
115 mg
IVEMEND 150 MG powd for sol for inf
150 mg
150 mg
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (0)
No result.
Croatia (7)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT ALPHA-MEDICAL 125 MG + 80 MG TVRDA caps, hard
1 caps od 125 mg i 2 caps od 80 mg u dže
Y
Rx
-
A04AD12
APREPITANT SANDOZ 125 MG + 80 MG TVRDA caps, hard
1 caps od 125 mg in blister i 2 caps od
N
Rx
-
A04AD12
APREPITANT SANDOZ 125 MG TVRDA caps, hard
1 caps in blister
2 caps in blister
3 caps in blister
5 caps in blister
N
N
N
N
Rx
Rx
Rx
Rx
-
A04AD12
APREPITANT SANDOZ 80 MG TVRDA caps, hard
1 caps in blister
2 caps in blister
3 caps in blister
5 caps in blister
T
T
T
T
Rx
Rx
Rx
Rx
-
A04AD12
APREPITANT TEVA 125 MG + 80 MG TVRDA caps, hard
jedna caps in blister i dvije caps in bl
Y
Rx
-
A04AD12
EMEND -
Y
Rx
-
A04AD12
IVEMEND -
-
Rx
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT ALPHA-MEDICAL 125 MG + 80 MG TVRDA caps, hard
1 caps od 125 mg i 2 caps od 80 mg u dže
HR-H-359140886-01
30-04-2020
30-04-2025
APREPITANT SANDOZ 125 MG + 80 MG TVRDA caps, hard
1 caps od 125 mg in blister i 2 caps od
HR-H-208260366-01
10-10-2018
10-10-2023
APREPITANT SANDOZ 125 MG TVRDA caps, hard
1 caps in blister
2 caps in blister
3 caps in blister
5 caps in blister
HR-H-860255103-01
HR-H-860255103-02
HR-H-860255103-03
HR-H-860255103-04
19-01-2018
19-01-2018
19-01-2018
19-01-2018
19-01-2023
19-01-2023
19-01-2023
19-01-2023
APREPITANT SANDOZ 80 MG TVRDA caps, hard
1 caps in blister
2 caps in blister
3 caps in blister
5 caps in blister
HR-H-968660473-01
HR-H-968660473-02
HR-H-968660473-03
HR-H-968660473-04
19-01-2018
19-01-2018
19-01-2018
19-01-2018
19-01-2023
19-01-2023
19-01-2023
19-01-2023
09-03-2021
09-03-2021
09-03-2021
09-03-2021
APREPITANT TEVA 125 MG + 80 MG TVRDA caps, hard
jedna caps in blister i dvije caps in bl
HR-H-083770930-01
06-07-2018
06-07-2023
EMEND -
IVEMEND -
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Czechia (10)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT ACCORD 125MG caps, hard
125MG 5
N
oral
A04AD12
APREPITANT ACCORD 80MG caps, hard
80MG 2
80MG 5
N
N
oral
A04AD12
APREPITANT ACCORD 80MG+125MG caps, hard
80MG+125MG 2+1
N
oral
A04AD12
APREPITANT SANDOZ 125MG+80MG caps, hard
125MG+80MG 1+2
Y
oral
A04AD12
APREPITANT TEVA 125MG+80MG caps, hard
125MG+80MG 1+2
Y
oral
A04AD12
EMEND 125MG caps, hard
125MG 1
125MG 5
N
N
oral
A04AD12
EMEND 125MG powd for oral susp
125MG 1
N
oral
A04AD12
EMEND 125MG+80MG caps, hard
125MG+80MG 1+2
Y
oral
A04AD12
EMEND 80MG caps, hard
80MG 1
80MG 2
80MG 5
N
N
N
oral
A04AD12
IVEMEND 150MG powd for sol for inf
150MG 1
150MG 10
N
N
iv
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT ACCORD 125MG caps, hard
125MG 5
20/ 276/17-C
MRP/DCP
APREPITANT ACCORD 80MG caps, hard
80MG 2
80MG 5
20/ 275/17-C
20/ 275/17-C
MRP/DCP
MRP/DCP
APREPITANT ACCORD 80MG+125MG caps, hard
80MG+125MG 2+1
20/ 345/17-C
MRP/DCP
APREPITANT SANDOZ 125MG+80MG caps, hard
125MG+80MG 1+2
20/1038/16-C
MRP/DCP
APREPITANT TEVA 125MG+80MG caps, hard
125MG+80MG 1+2
20/ 168/17-C
MRP/DCP
EMEND 125MG caps, hard
125MG 1
125MG 5
EU/1/03/262/004
EU/1/03/262/005
CP
CP
EMEND 125MG powd for oral susp
125MG 1
EU/1/03/262/011
CP
EMEND 125MG+80MG caps, hard
125MG+80MG 1+2
EU/1/03/262/006
CP
EMEND 80MG caps, hard
80MG 1
80MG 2
80MG 5
EU/1/03/262/001
EU/1/03/262/002
EU/1/03/262/003
CP
CP
CP
IVEMEND 150MG powd for sol for inf
150MG 1
150MG 10
EU/1/07/437/003
EU/1/07/437/004
CP
CP
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
APREPITANT ACCORD 125MG caps, hard
125MG 5
0
APREPITANT ACCORD 80MG caps, hard
80MG 2
80MG 5
0
0
APREPITANT ACCORD 80MG+125MG caps, hard
80MG+125MG 2+1
1221,38
1663,22
APREPITANT SANDOZ 125MG+80MG caps, hard
125MG+80MG 1+2
1221,38
1663,22
APREPITANT TEVA 125MG+80MG caps, hard
125MG+80MG 1+2
732,82
1025,62
EMEND 125MG caps, hard
125MG 1
125MG 5
0
0
EMEND 125MG powd for oral susp
125MG 1
0
EMEND 125MG+80MG caps, hard
125MG+80MG 1+2
1221,38
1663,22
EMEND 80MG caps, hard
80MG 1
80MG 2
80MG 5
0
0
0
IVEMEND 150MG powd for sol for inf
150MG 1
150MG 10
0
0
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Denmark (17)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT MEDICAL VALLEY 125 MG caps, hard
-
-
A04AD12
APREPITANT MEDICAL VALLEY 125+80 MG caps, hard
-
-
A04AD12
APREPITANT MEDICAL VALLEY 40 MG caps, hard
-
-
A04AD12
APREPITANT MEDICAL VALLEY 80 MG caps, hard
-
-
A04AD12
APREPITANT SANDOZ 125+80 MG caps, hard
-
-
A04AD12
APREPITANT STADA 125 MG caps, hard
-
-
A04AD12
APREPITANT STADA 125+80 MG caps, hard
-
-
A04AD12
APREPITANT STADA 80 MG caps, hard
-
-
A04AD12
ATANTO 125 MG caps, hard
-
-
A04AD12
ATANTO 125+80 MG caps, hard
-
-
A04AD12
ATANTO 40 MG caps, hard
-
-
A04AD12
ATANTO 80 MG caps, hard
-
-
A04AD12
EMEND 125 MG caps, hard
-
-
A04AD12
EMEND 125 MG powd for oral susp
-
-
A04AD12
EMEND 125 MG+80 MG caps, hard
-
-
A04AD12
EMEND 80 MG caps, hard
-
-
A04AD12
IVEMEND 150 MG powd for sol for inf
-
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT MEDICAL VALLEY 125 MG caps, hard
28105981717
DCP
03-05-2019
APREPITANT MEDICAL VALLEY 125+80 MG caps, hard
28106256517
DCP
03-05-2019
APREPITANT MEDICAL VALLEY 40 MG caps, hard
28105981517
DCP
03-05-2019
APREPITANT MEDICAL VALLEY 80 MG caps, hard
28105981617
DCP
03-05-2019
APREPITANT SANDOZ 125+80 MG caps, hard
28105898416
DCP
21-06-2018
APREPITANT STADA 125 MG caps, hard
28105978917
DCP
15-02-2019
APREPITANT STADA 125+80 MG caps, hard
28106228217
DCP
15-02-2019
APREPITANT STADA 80 MG caps, hard
28105978817
DCP
15-02-2019
ATANTO 125 MG caps, hard
28105982417
DCP
24-09-2019
ATANTO 125+80 MG caps, hard
28106334617
DCP
24-09-2019
ATANTO 40 MG caps, hard
28105982217
DCP
24-09-2019
ATANTO 80 MG caps, hard
28105982317
DCP
24-09-2019
EMEND 125 MG caps, hard
28103454302
CP
11-11-2003
EMEND 125 MG powd for oral susp
28105550214
CP
16-12-2015
EMEND 125 MG+80 MG caps, hard
28103605502
CP
11-11-2003
EMEND 80 MG caps, hard
28103454202
CP
11-11-2003
IVEMEND 150 MG powd for sol for inf
28104621109
CP
31-08-2010
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
APREPITANT MEDICAL VALLEY 125 MG caps, hard
APREPITANT MEDICAL VALLEY 125+80 MG caps, hard
APREPITANT MEDICAL VALLEY 40 MG caps, hard
APREPITANT MEDICAL VALLEY 80 MG caps, hard
APREPITANT SANDOZ 125+80 MG caps, hard
APREPITANT STADA 125 MG caps, hard
APREPITANT STADA 125+80 MG caps, hard
APREPITANT STADA 80 MG caps, hard
ATANTO 125 MG caps, hard
ATANTO 125+80 MG caps, hard
ATANTO 40 MG caps, hard
ATANTO 80 MG caps, hard
EMEND 125 MG caps, hard
EMEND 125 MG powd for oral susp
EMEND 125 MG+80 MG caps, hard
EMEND 80 MG caps, hard
IVEMEND 150 MG powd for sol for inf
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Finland (12)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT STADA 125 MG caps, hard
1x in blister
5x in blister
N
Y
Rx
Rx
-
A04AD12
APREPITANT STADA 125 MG + 80 MG caps, hard
1 (125mg) + 2 (80mg) in blister
Y
Rx
-
A04AD12
APREPITANT STADA 80 MG caps, hard
1x in blister
2x in blister
5x in blister
N
Y
Y
Rx
Rx
Rx
-
A04AD12
EMEND 125 MG caps, hard
1x in blister
5 x 1 in blister
N
Y
Rx
Rx
-
A04AD12
EMEND 125 MG powd for oral susp
1x in bag
N
Rx
-
A04AD12
EMEND 125 MG + 80 MG caps, hard
125 mg + 2 x 80 mg in blister
Y
Rx
-
A04AD12
EMEND 125 MG + 80 MG caps, hard
125 mg + 2 x 80 mg in blister
N
Rx
-
A04AD12
EMEND 165 MG caps, hard
1x in blister
6 x 1 in blister
N
N
Rx
Rx
-
A04AD12
EMEND 40 MG caps, hard
1x in blister
5x in blister
N
N
Rx
Rx
-
A04AD12
EMEND 80 MG caps, hard
1x in blister
2x in blister
5 x 1 in blister
N
Y
N
Rx
Rx
Rx
-
A04AD12
FOSAPREPITANT ACCORD 150 MG powd for sol for inf
150 mg in vial
N
Rx
-
A04AD12
IVEMEND 150 MG powd for sol for inf
10 x 150 mg in vial
150 mg in vial
N
Y
Rx
Rx
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT STADA 125 MG caps, hard
1x in blister
5x in blister
35342
35342
-
-
04-03-2019
04-03-2019
APREPITANT STADA 125 MG + 80 MG caps, hard
1 (125mg) + 2 (80mg) in blister
35414
-
04-03-2019
APREPITANT STADA 80 MG caps, hard
1x in blister
2x in blister
5x in blister
35341
35341
35341
-
-
-
04-03-2019
04-03-2019
04-03-2019
EMEND 125 MG caps, hard
1x in blister
5 x 1 in blister
-
-
11-11-2003
11-11-2003
EMEND 125 MG powd for oral susp
1x in bag
-
16-12-2015
EMEND 125 MG + 80 MG caps, hard
125 mg + 2 x 80 mg in blister
-
11-11-2003
EMEND 125 MG + 80 MG caps, hard
125 mg + 2 x 80 mg in blister
PI
26-09-2014
EMEND 165 MG caps, hard
1x in blister
6 x 1 in blister
-
-
28-11-2011
28-11-2011
EMEND 40 MG caps, hard
1x in blister
5x in blister
-
-
29-05-2006
29-05-2006
EMEND 80 MG caps, hard
1x in blister
2x in blister
5 x 1 in blister
-
-
-
11-11-2003
11-11-2003
11-11-2003
FOSAPREPITANT ACCORD 150 MG powd for sol for inf
150 mg in vial
34783
-
28-02-2018
IVEMEND 150 MG powd for sol for inf
10 x 150 mg in vial
150 mg in vial
-
-
31-08-2010
31-08-2010
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Hungary (19)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT PHARMACENTER 125 MG caps, hard
1x1 blister
1x2 blister
5x1 blister
N
N
N
Rx
Rx
Rx
-
A04AD12
APREPITANT PHARMACENTER 125 MG + APREPITANT PHARMACENTER 80 caps, hard
1x125mg blister +2x80 mg blister
Y
Rx
oral
A04AD12
APREPITANT PHARMACENTER 80 MG caps, hard
1x1 blister
1x2 blister
3x1 blister
5x1 blister
N
N
N
N
Rx
Rx
Rx
Rx
-
A04AD12
APREPITANT RONTIS 125 MG caps, hard
1x1 blister
5x1 blister
N
N
Rx
Rx
-
A04AD12
APREPITANT RONTIS 125 MG + APREPITANT RONTIS 80 MG caps, hard
1x125mg blister +2x80 mg
N
Rx
-
A04AD12
APREPITANT RONTIS 80 MG caps, hard
1x1 blister
1x2 blister
3x1 blister
5x1 blister
N
N
N
N
Rx
Rx
Rx
Rx
-
A04AD12
APREPITANT SANDOZ 125 MG caps, hard
1x blister
2x blister
3x1 blister
5x1 blister
N
N
N
N
Rx
Rx
Rx
Rx
-
A04AD12
APREPITANT SANDOZ 125 MG + APREPITANT SANDOZ 80 MG caps, hard
2x80mg blister +1x125 mg
N
Rx
-
A04AD12
APREPITANT SANDOZ 80 MG caps, hard
1x blister
2x blister
3x1 blister
5x1 blister
N
N
N
N
Rx
Rx
Rx
Rx
-
A04AD12
APREPITANT-Q PHARMA 125 MG caps, hard
1x1 blister
5x1 blister
N
N
Rx
Rx
-
A04AD12
APREPITANT-Q PHARMA 125 MG + APREPITANT-Q PHARMA 80 MG caps, hard
1x125 mg + 2x80mg blister
N
Rx
-
A04AD12
APREPITANT-Q PHARMA 80 MG caps, hard
1x1 blister
1x2 blister
3x1 blister
5x1 blister
N
N
N
N
Rx
Rx
Rx
Rx
-
A04AD12
EMEND 125 MG caps, hard
1x
5x1
N
N
Rx
Rx
oral
A04AD12
EMEND 125 MG powd for oral susp
1x sachet +2 adagoló syringe+1 kupak+1 k
N
Rx
-
A04AD12
EMEND 125 MG EMEND 80 MG caps, hard
1x125mg +2x80 mg
Y
Rx
oral
A04AD12
EMEND 165 MG caps, hard
1x blister
6x blister
N
N
Rx
Rx
-
A04AD12
EMEND 40 MG caps, hard
1x
5x1
N
N
Rx
Rx
oral
A04AD12
EMEND 80 MG caps, hard
1x
2x
5x1
N
N
N
Rx
Rx
Rx
oral
A04AD12
IVEMEND 150 MG powd for sol for inf
10x10ml vial
1x10ml vial
N
N
Rx
Rx
parenteral
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT PHARMACENTER 125 MG caps, hard
1x1 blister
1x2 blister
5x1 blister
OGYI-T-23605/05
OGYI-T-23605/06
OGYI-T-23605/07
28-10-2019
28-10-2019
28-10-2019
APREPITANT PHARMACENTER 125 MG + APREPITANT PHARMACENTER 80 caps, hard
1x125mg blister +2x80 mg blister
OGYI-T-23605/08
28-10-2019
APREPITANT PHARMACENTER 80 MG caps, hard
1x1 blister
1x2 blister
3x1 blister
5x1 blister
OGYI-T-23605/01
OGYI-T-23605/02
OGYI-T-23605/03
OGYI-T-23605/04
APREPITANT RONTIS 125 MG caps, hard
1x1 blister
5x1 blister
OGYI-T-23396/05
OGYI-T-23396/06
20-06-2018
20-06-2018
APREPITANT RONTIS 125 MG + APREPITANT RONTIS 80 MG caps, hard
1x125mg blister +2x80 mg
OGYI-T-23396/07
20-06-2018
APREPITANT RONTIS 80 MG caps, hard
1x1 blister
1x2 blister
3x1 blister
5x1 blister
OGYI-T-23396/01
OGYI-T-23396/02
OGYI-T-23396/03
OGYI-T-23396/04
APREPITANT SANDOZ 125 MG caps, hard
1x blister
2x blister
3x1 blister
5x1 blister
OGYI-T-23314/05
OGYI-T-23314/06
OGYI-T-23314/07
OGYI-T-23314/08
11-01-2018
11-01-2018
11-01-2018
11-01-2018
APREPITANT SANDOZ 125 MG + APREPITANT SANDOZ 80 MG caps, hard
2x80mg blister +1x125 mg
OGYI-T-23314/09
11-01-2018
APREPITANT SANDOZ 80 MG caps, hard
1x blister
2x blister
3x1 blister
5x1 blister
OGYI-T-23314/01
OGYI-T-23314/02
OGYI-T-23314/03
OGYI-T-23314/04
APREPITANT-Q PHARMA 125 MG caps, hard
1x1 blister
5x1 blister
OGYI-T-23678/05
OGYI-T-23678/06
19-05-2020
19-05-2020
APREPITANT-Q PHARMA 125 MG + APREPITANT-Q PHARMA 80 MG caps, hard
1x125 mg + 2x80mg blister
OGYI-T-23678/07
19-05-2020
APREPITANT-Q PHARMA 80 MG caps, hard
1x1 blister
1x2 blister
3x1 blister
5x1 blister
OGYI-T-23678/01
OGYI-T-23678/02
OGYI-T-23678/03
OGYI-T-23678/04
EMEND 125 MG caps, hard
1x
5x1
EU/1/03/262/004
EU/1/03/262/005
11-11-2003
11-11-2003
EMEND 125 MG powd for oral susp
1x sachet +2 adagoló syringe+1 kupak+1 k
EU/1/03/262/011
16-12-2015
EMEND 125 MG EMEND 80 MG caps, hard
1x125mg +2x80 mg
EU/1/03/262/006
12-11-2003
EMEND 165 MG caps, hard
1x blister
6x blister
EU/1/03/262/009
EU/1/03/262/010
28-11-2011
28-11-2011
EMEND 40 MG caps, hard
1x
5x1
EU/1/03/262/007
EU/1/03/262/008
EMEND 80 MG caps, hard
1x
2x
5x1
EU/1/03/262/001
EU/1/03/262/002
EU/1/03/262/003
IVEMEND 150 MG powd for sol for inf
10x10ml vial
1x10ml vial
EU/1/07/437/004
EU/1/07/437/003
31-08-2010
31-08-2010
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
APREPITANT PHARMACENTER 125 MG caps, hard
1x1 blister
1x2 blister
5x1 blister
0
0
0
0
0
0
0
0
0
0
0
0
APREPITANT PHARMACENTER 125 MG + APREPITANT PHARMACENTER 80 caps, hard
1x125mg blister +2x80 mg blister
9130
9531,72
10522
11048
APREPITANT PHARMACENTER 80 MG caps, hard
1x1 blister
1x2 blister
3x1 blister
5x1 blister
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
APREPITANT RONTIS 125 MG caps, hard
1x1 blister
5x1 blister
0
0
0
0
0
0
0
0
APREPITANT RONTIS 125 MG + APREPITANT RONTIS 80 MG caps, hard
1x125mg blister +2x80 mg
0
0
0
0
APREPITANT RONTIS 80 MG caps, hard
1x1 blister
1x2 blister
3x1 blister
5x1 blister
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
APREPITANT SANDOZ 125 MG caps, hard
1x blister
2x blister
3x1 blister
5x1 blister
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
APREPITANT SANDOZ 125 MG + APREPITANT SANDOZ 80 MG caps, hard
2x80mg blister +1x125 mg
0
0
0
0
APREPITANT SANDOZ 80 MG caps, hard
1x blister
2x blister
3x1 blister
5x1 blister
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
APREPITANT-Q PHARMA 125 MG caps, hard
1x1 blister
5x1 blister
0
0
0
0
0
0
0
0
APREPITANT-Q PHARMA 125 MG + APREPITANT-Q PHARMA 80 MG caps, hard
1x125 mg + 2x80mg blister
0
0
0
0
APREPITANT-Q PHARMA 80 MG caps, hard
1x1 blister
1x2 blister
3x1 blister
5x1 blister
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
EMEND 125 MG caps, hard
1x
5x1
0
0
0
0
0
0
0
0
EMEND 125 MG powd for oral susp
1x sachet +2 adagoló syringe+1 kupak+1 k
0
0
0
0
EMEND 125 MG EMEND 80 MG caps, hard
1x125mg +2x80 mg
15217
15886,55
16877
17721
EMEND 165 MG caps, hard
1x blister
6x blister
0
0
0
0
0
0
0
0
EMEND 40 MG caps, hard
1x
5x1
0
0
0
0
0
0
0
0
EMEND 80 MG caps, hard
1x
2x
5x1
0
0
0
0
0
0
0
0
0
0
0
0
IVEMEND 150 MG powd for sol for inf
10x10ml vial
1x10ml vial
0
0
0
0
0
0
0
0
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Iceland (29)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPILOR 125 MG caps, hard
N
Rx
-
A04AD12
APREPILOR 125 MG/80 MG caps, hard
N
Rx
-
A04AD12
APREPILOR 80 MG caps, hard
N
Rx
-
A04AD12
APREPITANT MEDICAL VALLEY 125 MG caps, hard
N
Rx
-
A04AD12
APREPITANT MEDICAL VALLEY 125 MG + 80 MG caps, hard
Y
Rx
-
A04AD12
APREPITANT MEDICAL VALLEY 40 MG caps, hard
N
Rx
-
A04AD12
APREPITANT MEDICAL VALLEY 80 MG caps, hard
N
Rx
-
A04AD12
APREPITANT MYLAN 125 MG caps, hard
N
Rx
-
A04AD12
APREPITANT MYLAN 125 MG/80 MG caps, hard
N
Rx
-
A04AD12
APREPITANT MYLAN 80 MG caps, hard
N
Rx
-
A04AD12
ATANTO 125 MG caps, hard
N
Rx
-
A04AD12
ATANTO 125MG/80MG MG caps, hard
N
Rx
-
A04AD12
ATANTO 80 MG caps, hard
N
Rx
-
A04AD12
EMEND 125 MG caps, hard
N
Rx
-
A04AD12
EMEND 125 MG powd for oral susp
N
Rx
-
A04AD12
EMEND 165 MG caps, hard
N
Rx
-
A04AD12
EMEND 40 MG caps, hard
N
Rx
-
A04AD12
EMEND 80 MG caps, hard
N
Rx
-
A04AD12
EMEND 80+125 MG caps, hard
Y
Rx
-
A04AD12
IVEMEND 150 MG powd for sol for inf
N
Rx
-
A04AD12
LORPITAN 125 MG caps, hard
N
Rx
-
A04AD12
LORPITAN 125 MG/80 MG caps, hard
N
Rx
-
A04AD12
LORPITAN 80 MG caps, hard
N
Rx
-
A04AD12
PARPILAN 125 MG caps, hard
N
Rx
-
A04AD12
PARPILAN 125 MG/80 MG caps, hard
N
Rx
-
A04AD12
PARPILAN 80 MG caps, hard
N
Rx
-
A04AD12
TIPERANT 125 MG caps, hard
N
Rx
-
A04AD12
TIPERANT 125/80 MG caps, hard
N
Rx
-
A04AD12
TIPERANT 80 MG caps, hard
N
Rx
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPILOR 125 MG caps, hard
21-06-2017
APREPILOR 125 MG/80 MG caps, hard
21-06-2017
APREPILOR 80 MG caps, hard
21-06-2017
APREPITANT MEDICAL VALLEY 125 MG caps, hard
18-01-2019
APREPITANT MEDICAL VALLEY 125 MG + 80 MG caps, hard
18-01-2019
APREPITANT MEDICAL VALLEY 40 MG caps, hard
18-01-2019
APREPITANT MEDICAL VALLEY 80 MG caps, hard
18-01-2019
APREPITANT MYLAN 125 MG caps, hard
21-06-2017
APREPITANT MYLAN 125 MG/80 MG caps, hard
21-06-2017
APREPITANT MYLAN 80 MG caps, hard
21-06-2017
ATANTO 125 MG caps, hard
18-01-2019
ATANTO 125MG/80MG MG caps, hard
18-01-2019
ATANTO 80 MG caps, hard
18-01-2019
EMEND 125 MG caps, hard
11-12-2003
EMEND 125 MG powd for oral susp
16-12-2015
EMEND 165 MG caps, hard
28-11-2011
EMEND 40 MG caps, hard
19-06-2006
EMEND 80 MG caps, hard
11-12-2003
EMEND 80+125 MG caps, hard
11-12-2003
IVEMEND 150 MG powd for sol for inf
23-09-2010
LORPITAN 125 MG caps, hard
02-07-2018
LORPITAN 125 MG/80 MG caps, hard
02-07-2018
LORPITAN 80 MG caps, hard
02-07-2018
PARPILAN 125 MG caps, hard
02-07-2018
PARPILAN 125 MG/80 MG caps, hard
02-07-2018
PARPILAN 80 MG caps, hard
02-07-2018
TIPERANT 125 MG caps, hard
02-07-2018
TIPERANT 125/80 MG caps, hard
02-07-2018
TIPERANT 80 MG caps, hard
02-07-2018
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
APREPILOR 125 MG caps, hard
APREPILOR 125 MG/80 MG caps, hard
APREPILOR 80 MG caps, hard
APREPITANT MEDICAL VALLEY 125 MG caps, hard
APREPITANT MEDICAL VALLEY 125 MG + 80 MG caps, hard
APREPITANT MEDICAL VALLEY 40 MG caps, hard
APREPITANT MEDICAL VALLEY 80 MG caps, hard
APREPITANT MYLAN 125 MG caps, hard
APREPITANT MYLAN 125 MG/80 MG caps, hard
APREPITANT MYLAN 80 MG caps, hard
ATANTO 125 MG caps, hard
ATANTO 125MG/80MG MG caps, hard
ATANTO 80 MG caps, hard
EMEND 125 MG caps, hard
EMEND 125 MG powd for oral susp
EMEND 165 MG caps, hard
EMEND 40 MG caps, hard
EMEND 80 MG caps, hard
EMEND 80+125 MG caps, hard
IVEMEND 150 MG powd for sol for inf
LORPITAN 125 MG caps, hard
LORPITAN 125 MG/80 MG caps, hard
LORPITAN 80 MG caps, hard
PARPILAN 125 MG caps, hard
PARPILAN 125 MG/80 MG caps, hard
PARPILAN 80 MG caps, hard
TIPERANT 125 MG caps, hard
TIPERANT 125/80 MG caps, hard
TIPERANT 80 MG caps, hard
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Ireland (9)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT ACCORD 125 MG HARD caps, hard
Y
Rx
oral
A04AD12
APREPITANT ACCORD 125 MG/80 MG HARD 80/125 MG caps, hard
Y
Rx
oral
A04AD12
APREPITANT ACCORD 80 MG HARD caps, hard
-
Rx
oral
A04AD12
EMEND 125 MG powd for oral sol
-
Rx
-
A04AD12
EMEND 165 MG caps, hard
-
Rx
oral
A04AD12
EMEND 40 MG caps, hard
-
Rx
-
A04AD12
EMEND 80 &125 MG MG caps, hard
-
Rx
oral
A04AD12
IVEMEND 115 MG powd for sol for inf
-
Rx
iv
A04AD12
IVEMEND 150 MG powd for sol for inf
-
Rx
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT ACCORD 125 MG HARD caps, hard
PA2315/148/002
22-03-2019
APREPITANT ACCORD 125 MG/80 MG HARD 80/125 MG caps, hard
PA2315/148/003
22-03-2019
APREPITANT ACCORD 80 MG HARD caps, hard
PA2315/148/001
22-03-2019
EMEND 125 MG powd for oral sol
EU/1/03/262/011
16-12-2015
EMEND 165 MG caps, hard
EU/1/03/262/009-010
28-11-2011
EMEND 40 MG caps, hard
EU/1/03/262/7-8
29-08-2006
EMEND 80 &125 MG MG caps, hard
EU/1/03/262/1-6
11-11-2003
IVEMEND 115 MG powd for sol for inf
EU/1/07/437/001-2
IVEMEND 150 MG powd for sol for inf
EU/1/07/437/003-004
31-08-2010
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (8)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT SANDOZ 125 MG + 80 MG caps, hard
N1 (125 mg) + N2 (80 mg) blister
Rx
oral
A04AD12
EMEND 125 MG caps, hard
N1 blister
N5x1 blister
Rx
Rx
oral
A04AD12
EMEND 125 MG powd for oral susp
milteliai, 2 geriamieji švirkštai, dangt
Rx
oral
A04AD12
EMEND 125 MG + 80 MG caps, hard
N(1+2) blister
Rx
oral
A04AD12
EMEND 165 MG caps, hard
N1 blister
N6x1 blister
Rx
Rx
oral
A04AD12
EMEND 40 MG caps, hard
N1 blister
N5x1 blister
Rx
Rx
oral
A04AD12
EMEND 80 MG caps, hard
N1 blister
N2 blister
N5x1 blister
Rx
Rx
Rx
oral
A04AD12
IVEMEND 150 MG powd for sol for inf
10 ml N1 vial
10 ml N10 vial
Rx
Rx
iv
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT SANDOZ 125 MG + 80 MG caps, hard
N1 (125 mg) + N2 (80 mg) blister
LT/1/18/4191/001
DCP
07-02-2018
EMEND 125 MG caps, hard
N1 blister
N5x1 blister
EU/1/03/262/004
EU/1/03/262/005
CP
CP
11-11-2003
11-11-2003
EMEND 125 MG powd for oral susp
milteliai, 2 geriamieji švirkštai, dangt
EU/1/03/262/011
CP
11-11-2003
EMEND 125 MG + 80 MG caps, hard
N(1+2) blister
EU/1/03/262/006
CP
11-11-2003
EMEND 165 MG caps, hard
N1 blister
N6x1 blister
EU/1/03/262/009
EU/1/03/262/010
CP
CP
28-11-2011
28-11-2011
EMEND 40 MG caps, hard
N1 blister
N5x1 blister
EU/1/03/262/007
EU/1/03/262/008
CP
CP
29-05-2006
29-05-2006
EMEND 80 MG caps, hard
N1 blister
N2 blister
N5x1 blister
EU/1/03/262/001
EU/1/03/262/002
EU/1/03/262/003
CP
CP
CP
11-11-2003
11-11-2003
11-11-2003
IVEMEND 150 MG powd for sol for inf
10 ml N1 vial
10 ml N10 vial
EU/1/07/437/003
EU/1/07/437/004
CP
CP
11-01-2008
11-01-2008
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Malta (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT RONTIS HARD 125MG caps, hard
Rx
-
A04AD12
APREPITANT RONTIS HARD 80MG caps, hard
Rx
-
A04AD12
APREPITANT RONTIS HARD 80MG & 125MG caps, hard
Rx
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT RONTIS HARD 125MG caps, hard
MA1208/00202
24-04-2018
APREPITANT RONTIS HARD 80MG caps, hard
MA1208/00201
25-04-2018
APREPITANT RONTIS HARD 80MG & 125MG caps, hard
MA1208/00203
24-04-2018
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Netherlands (38)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT ACCORD 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT ACCORD 125 MG/80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT ACCORD 40 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT ACCORD 80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT AUROBINDO 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT AUROBINDO 80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT AUROBINDO 80 MG + 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT BETA 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT BETA 80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT BETA 80 MG + 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT CF 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT CF 40 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT CF 80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT CF 80 MG PLUS 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT SANDOZ 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT SANDOZ 125 MG + 80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT SANDOZ 80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT TEVA 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT TEVA 125 MG + 80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT TEVA 80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT XIROMED 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT XIROMED 40 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT XIROMED 80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT XIROMED 80 MG + 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT ZENTIVA 125 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT ZENTIVA 125 MG + 80 MG caps, hard
-
Rx
oral
A04AD12
APREPITANT ZENTIVA 80 MG caps, hard
-
Rx
oral
A04AD12
ATANTO 125 MG caps, hard
-
Rx
oral
A04AD12
ATANTO 125 MG/80 MG caps, hard
-
Rx
oral
A04AD12
ATANTO 40 MG caps, hard
-
Rx
oral
A04AD12
ATANTO 80 MG caps, hard
-
Rx
oral
A04AD12
EMEND 125 MG caps
-
Rx
-
A04AD12
EMEND 125 MG powd for oral susp
-
Rx
-
A04AD12
EMEND 125 MG EN 80 MG caps
-
Rx
-
A04AD12
EMEND 165 MG capsule hard
-
Rx
-
A04AD12
EMEND 40 MG caps
-
Rx
-
A04AD12
EMEND 80 MG caps
-
Rx
-
A04AD12
IVEMEND poeder voor oplossing voor injectie dragees mg
-
Rx
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT ACCORD 125 MG caps, hard
RVG 121539
-
01-04-2019
APREPITANT ACCORD 125 MG/80 MG caps, hard
RVG 121804
-
01-04-2019
APREPITANT ACCORD 40 MG caps, hard
RVG 121537
-
01-04-2019
APREPITANT ACCORD 80 MG caps, hard
RVG 121538
-
01-04-2019
APREPITANT AUROBINDO 125 MG caps, hard
RVG 122855
-
01-04-2019
APREPITANT AUROBINDO 80 MG caps, hard
RVG 122854
-
01-04-2019
APREPITANT AUROBINDO 80 MG + 125 MG caps, hard
RVG 122856
-
01-04-2019
APREPITANT BETA 125 MG caps, hard
RVG 122846
-
01-04-2019
APREPITANT BETA 80 MG caps, hard
RVG 122845
-
01-04-2019
APREPITANT BETA 80 MG + 125 MG caps, hard
RVG 122847
-
01-04-2019
APREPITANT CF 125 MG caps, hard
RVG 121533
-
17-01-2019
APREPITANT CF 40 MG caps, hard
RVG 121531
-
17-01-2019
APREPITANT CF 80 MG caps, hard
RVG 121532
-
17-01-2019
APREPITANT CF 80 MG PLUS 125 MG caps, hard
RVG 121803
-
17-01-2019
APREPITANT SANDOZ 125 MG caps, hard
RVG 120490
-
24-04-2018
APREPITANT SANDOZ 125 MG + 80 MG caps, hard
RVG 120491
-
24-04-2018
APREPITANT SANDOZ 80 MG caps, hard
RVG 120489
-
24-04-2018
APREPITANT TEVA 125 MG caps, hard
RVG 121087
-
10-07-2018
APREPITANT TEVA 125 MG + 80 MG caps, hard
RVG 121088
-
10-07-2018
APREPITANT TEVA 80 MG caps, hard
RVG 121086
-
10-07-2018
APREPITANT XIROMED 125 MG caps, hard
RVG 121536
-
01-04-2019
APREPITANT XIROMED 40 MG caps, hard
RVG 121534
-
01-04-2019
APREPITANT XIROMED 80 MG caps, hard
RVG 121535
-
01-04-2019
APREPITANT XIROMED 80 MG + 125 MG caps, hard
RVG 121802
-
01-04-2019
APREPITANT ZENTIVA 125 MG caps, hard
RVG 123042
-
01-04-2019
APREPITANT ZENTIVA 125 MG + 80 MG caps, hard
RVG 123043
-
01-04-2019
APREPITANT ZENTIVA 80 MG caps, hard
RVG 123041
-
01-04-2019
ATANTO 125 MG caps, hard
RVG 121530
-
01-04-2019
ATANTO 125 MG/80 MG caps, hard
RVG 121801
-
01-04-2019
ATANTO 40 MG caps, hard
RVG 121527
-
01-04-2019
ATANTO 80 MG caps, hard
RVG 121528
-
01-04-2019
EMEND 125 MG caps
EU/1/03/262
-
11-11-2003
EMEND 125 MG powd for oral susp
EU/1/03/262
-
16-12-2015
EMEND 125 MG EN 80 MG caps
EU/1/03/262
-
11-11-2003
EMEND 165 MG capsule hard
EU/1/03/262
-
28-11-2011
EMEND 40 MG caps
EU/1/03/262
-
19-05-2006
EMEND 80 MG caps
EU/1/03/262
-
11-11-2003
IVEMEND poeder voor oplossing voor injectie dragees mg
EU/1/07/437
-
31-08-2010
Product
Pack
SPC
PIL
Company
APREPITANT ACCORD 125 MG caps, hard
APREPITANT ACCORD 125 MG/80 MG caps, hard
APREPITANT ACCORD 40 MG caps, hard
APREPITANT ACCORD 80 MG caps, hard
APREPITANT AUROBINDO 125 MG caps, hard
APREPITANT AUROBINDO 80 MG caps, hard
APREPITANT AUROBINDO 80 MG + 125 MG caps, hard
APREPITANT BETA 125 MG caps, hard
APREPITANT BETA 80 MG caps, hard
APREPITANT BETA 80 MG + 125 MG caps, hard
APREPITANT CF 125 MG caps, hard
APREPITANT CF 40 MG caps, hard
APREPITANT CF 80 MG caps, hard
APREPITANT CF 80 MG PLUS 125 MG caps, hard
APREPITANT SANDOZ 125 MG caps, hard
APREPITANT SANDOZ 125 MG + 80 MG caps, hard
APREPITANT SANDOZ 80 MG caps, hard
APREPITANT TEVA 125 MG caps, hard
APREPITANT TEVA 125 MG + 80 MG caps, hard
APREPITANT TEVA 80 MG caps, hard
APREPITANT XIROMED 125 MG caps, hard
APREPITANT XIROMED 40 MG caps, hard
APREPITANT XIROMED 80 MG caps, hard
APREPITANT XIROMED 80 MG + 125 MG caps, hard
APREPITANT ZENTIVA 125 MG caps, hard
APREPITANT ZENTIVA 125 MG + 80 MG caps, hard
APREPITANT ZENTIVA 80 MG caps, hard
ATANTO 125 MG caps, hard
ATANTO 125 MG/80 MG caps, hard
ATANTO 40 MG caps, hard
ATANTO 80 MG caps, hard
EMEND 125 MG caps
EMEND 125 MG powd for oral susp
EMEND 125 MG EN 80 MG caps
EMEND 165 MG capsule hard
EMEND 40 MG caps
EMEND 80 MG caps
IVEMEND poeder voor oplossing voor injectie dragees mg
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Norway (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EMEND 125 MG caps, hard
1
2
5 x 1
-
-
-
Rx
Rx
Rx
oral
A04AD12
EMEND 80 MG caps, hard
1
2
2
-
-
-
Rx
Rx
Rx
oral
A04AD12
IVEMEND PULV TIL 150 MG powd for sol for inf
1 x 150
-
Rx
iv
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EMEND 125 MG caps, hard
1
2
5 x 1
01-01-2006
01-01-2006
01-02-2004
EMEND 80 MG caps, hard
1
2
2
01-01-2006
01-01-2006
01-09-2008
IVEMEND PULV TIL 150 MG powd for sol for inf
1 x 150
15-01-2011
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Poland (21)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT ACCORD 125 MG caps, hard
5 caps
-
Rx
-
A04AD12
APREPITANT ACCORD 40 MG caps, hard
1 caps
5 caps
-
-
Rx
Rx
-
A04AD12
APREPITANT ACCORD 80 MG caps, hard
2 caps
5 caps
-
-
Rx
Rx
-
A04AD12
APREPITANT ACCORD 80 MG; 125 MG caps, hard
3 caps (1 caps 125 mg + 2 caps 80 mg)
-
Rx
-
A04AD12
APREPITANT AUROVITAS 125 MG/80 MG caps, hard
3 caps (1 caps 125 mg + 2 caps 80 mg)
-
Rx
-
A04AD12
APREPITANT MYLAN 125 MG caps, hard
1 caps (1 x 1)
5 caps (5 x 1)
-
-
Rx
Rx
-
A04AD12
APREPITANT MYLAN 125 MG/80 MG caps, hard
3 caps (3 x 1)
-
Rx
-
A04AD12
APREPITANT MYLAN 80 MG caps, hard
1 caps (1 x 1)
2 caps (2 x 1)
5 caps (5 x 1)
-
-
-
Rx
Rx
Rx
-
A04AD12
APREPITANT SANDOZ 80 MG/125 MG caps, hard
1 caps 125 mg + 2 caps 80 mg
-
Rx
-
A04AD12
APREPITANT STADA 125 MG caps, hard
1 caps
5 caps
-
-
Rx
Rx
-
A04AD12
APREPITANT STADA 125 MG + 80 MG caps, hard
3 caps (1 caps 125 mg + 2 caps 80 mg)
-
Rx
-
A04AD12
APREPITANT STADA 40 MG caps, hard
1 caps
5 caps
-
-
Rx
Rx
-
A04AD12
APREPITANT STADA 80 MG caps, hard
1 caps
2 caps
5 caps
-
-
-
Rx
Rx
Rx
-
A04AD12
APREPITANT TEVA 125 MG / 80 MG caps, hard
1 caps 125 mg + 2 caps 80 mg
-
Rx
-
A04AD12
EMEND 125 MG caps, hard
1 caps
5 caps
-
-
Rx
Rx
-
A04AD12
EMEND 125 MG powd for oral susp
1 sachet
-
Rx
-
A04AD12
EMEND 125 MG + 80 MG caps, hard
1 caps 125 mg + 2 caps 80 mg
-
Rx
-
A04AD12
EMEND 165 MG caps, hard
1 caps
6 caps
-
-

-
A04AD12
EMEND 40 MG caps, hard
1 caps
5 caps
-
-

-
A04AD12
EMEND 80 MG caps, hard
1 caps
2 caps
5 caps
-
-
-
Rx
Rx
Rx
-
A04AD12
IVEMEND 150 MG powd for sol for inf
1 vial 10 ml
10 vial 10 ml
-
-
Rx
Rx
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT ACCORD 125 MG caps, hard
5 caps
25259
DCP
11-04-2024
APREPITANT ACCORD 40 MG caps, hard
1 caps
5 caps
25257
25257
DCP
DCP
11-04-2024
11-04-2024
APREPITANT ACCORD 80 MG caps, hard
2 caps
5 caps
25258
25258
DCP
DCP
11-04-2024
11-04-2024
APREPITANT ACCORD 80 MG; 125 MG caps, hard
3 caps (1 caps 125 mg + 2 caps 80 mg)
25260
DCP
11-04-2024
APREPITANT AUROVITAS 125 MG/80 MG caps, hard
3 caps (1 caps 125 mg + 2 caps 80 mg)
25200
DCP
20-03-2024
APREPITANT MYLAN 125 MG caps, hard
1 caps (1 x 1)
5 caps (5 x 1)
24419
24419
DCP
DCP
15-12-2020
15-12-2020
APREPITANT MYLAN 125 MG/80 MG caps, hard
3 caps (3 x 1)
24420
DCP
27-11-2022
APREPITANT MYLAN 80 MG caps, hard
1 caps (1 x 1)
2 caps (2 x 1)
5 caps (5 x 1)
24418
24418
24418
DCP
DCP
DCP
15-12-2020
15-12-2020
15-12-2020
APREPITANT SANDOZ 80 MG/125 MG caps, hard
1 caps 125 mg + 2 caps 80 mg
24538
DCP
06-02-2023
APREPITANT STADA 125 MG caps, hard
1 caps
5 caps
25505
25505
DCP
DCP
20-08-2024
20-08-2024
APREPITANT STADA 125 MG + 80 MG caps, hard
3 caps (1 caps 125 mg + 2 caps 80 mg)
25506
DCP
20-08-2024
APREPITANT STADA 40 MG caps, hard
1 caps
5 caps
25503
25503
DCP
DCP
20-08-2024
20-08-2024
APREPITANT STADA 80 MG caps, hard
1 caps
2 caps
5 caps
25504
25504
25504
DCP
DCP
DCP
20-08-2024
20-08-2024
20-08-2024
APREPITANT TEVA 125 MG / 80 MG caps, hard
1 caps 125 mg + 2 caps 80 mg
24916
DCP
13-09-2023
EMEND 125 MG caps, hard
1 caps
5 caps
CP
CP
EMEND 125 MG powd for oral susp
1 sachet
CP
EMEND 125 MG + 80 MG caps, hard
1 caps 125 mg + 2 caps 80 mg
CP
EMEND 165 MG caps, hard
1 caps
6 caps
CP
CP
EMEND 40 MG caps, hard
1 caps
5 caps
CP
CP
EMEND 80 MG caps, hard
1 caps
2 caps
5 caps
CP
CP
CP
IVEMEND 150 MG powd for sol for inf
1 vial 10 ml
10 vial 10 ml
CP
CP
Product
Pack
SPC
PIL
Company
APREPITANT ACCORD 125 MG caps, hard
5 caps
APREPITANT ACCORD 40 MG caps, hard
1 caps
5 caps
APREPITANT ACCORD 80 MG caps, hard
2 caps
5 caps
APREPITANT ACCORD 80 MG; 125 MG caps, hard
3 caps (1 caps 125 mg + 2 caps 80 mg)
APREPITANT AUROVITAS 125 MG/80 MG caps, hard
3 caps (1 caps 125 mg + 2 caps 80 mg)
APREPITANT MYLAN 125 MG caps, hard
1 caps (1 x 1)
5 caps (5 x 1)
APREPITANT MYLAN 125 MG/80 MG caps, hard
3 caps (3 x 1)
APREPITANT MYLAN 80 MG caps, hard
1 caps (1 x 1)
2 caps (2 x 1)
5 caps (5 x 1)
APREPITANT SANDOZ 80 MG/125 MG caps, hard
1 caps 125 mg + 2 caps 80 mg
APREPITANT STADA 125 MG caps, hard
1 caps
5 caps
APREPITANT STADA 125 MG + 80 MG caps, hard
3 caps (1 caps 125 mg + 2 caps 80 mg)
APREPITANT STADA 40 MG caps, hard
1 caps
5 caps
APREPITANT STADA 80 MG caps, hard
1 caps
2 caps
5 caps
APREPITANT TEVA 125 MG / 80 MG caps, hard
1 caps 125 mg + 2 caps 80 mg
EMEND 125 MG caps, hard
1 caps
5 caps
EMEND 125 MG powd for oral susp
1 sachet
EMEND 125 MG + 80 MG caps, hard
1 caps 125 mg + 2 caps 80 mg
EMEND 165 MG caps, hard
1 caps
6 caps
EMEND 40 MG caps, hard
1 caps
5 caps
EMEND 80 MG caps, hard
1 caps
2 caps
5 caps
IVEMEND 150 MG powd for sol for inf
1 vial 10 ml
10 vial 10 ml
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Romania (5)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT MYLAN 125 MG caps
blister perf single dose PA-Al-PVC/Al x
blister perforat single dose PA-Al-PVC/A
-
-
PRF
PRF
-
A04AD12
APREPITANT MYLAN 125 MG + 80 MG caps
blister perforat single dose PA-Al-PVC/A
-
PRF
-
A04AD12
APREPITANT MYLAN 80 MG caps
blister perf single dose PA-Al-PVC/Al x
blister perf single dose PA-Al-PVC/Al x
blister perforat single dose PA-Al-PVC/A
-
-
-
PRF
PRF
PRF
-
A04AD12
APREPITANT SANDOZ 125 MG+80 MG (PACHET) caps
1 blister OPA-Al-PVC/Al x 1 caps a 125 m
-
PRF
-
A04AD12
EMEND 125MG + 80MG caps
1 blister Al x 1 caps a 125 mg + 2 caps
-
PRF
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT MYLAN 125 MG caps
blister perf single dose PA-Al-PVC/Al x
blister perforat single dose PA-Al-PVC/A
-
-
APREPITANT MYLAN 125 MG + 80 MG caps
blister perforat single dose PA-Al-PVC/A
-
APREPITANT MYLAN 80 MG caps
blister perf single dose PA-Al-PVC/Al x
blister perf single dose PA-Al-PVC/Al x
blister perforat single dose PA-Al-PVC/A
-
-
-
APREPITANT SANDOZ 125 MG+80 MG (PACHET) caps
1 blister OPA-Al-PVC/Al x 1 caps a 125 m
-
EMEND 125MG + 80MG caps
1 blister Al x 1 caps a 125 mg + 2 caps
-
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Slovenia (12)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT MYLAN 125 MG caps, hard
1 kapsulo blister
-
Rx
oral
A04AD12
APREPITANT MYLAN 125 MG IN 80 MG caps, hard
1 kapsulo 125 mg aprepitanta in 2 capsma
-
Rx
oral
A04AD12
APREPITANT MYLAN 80 MG caps, hard
1 kapsulo blister
-
Rx
oral
A04AD12
APREPITANT SANDOZ 125 MG caps, hard
1 kapsulo (1 x 1 caps blister)
-
Rx
oral
A04AD12
APREPITANT SANDOZ 125 MG + APREPITANT SANDOZ 80 MG caps, hard
eno 125 mg kapsulo (1 x 1 caps blister)
-
Rx
oral
A04AD12
APREPITANT SANDOZ 80 MG caps, hard
2 capsma (1 x 2 kapsuli blister)
-
Rx
oral
A04AD12
APREPITANT TEVA 125 MG IN 80 MG caps, hard
1 pretisnim omotom 1 kapsulo 125 mg apre
N
Rx
oral
A04AD12
EMEND 125 MG caps, hard
1 caps blister
5 caps pretisnih omotih
-
-
Rx
Rx
oral
A04AD12
EMEND 125 MG , EMEND 80 MG caps, hard
1 caps 125mg in 2 kapsuli 80mg pretisnih
N
Rx
oral
A04AD12
EMEND 80 MG caps, hard
1 caps blister
2 kapsuli blister
5 caps pretisnih omotih
-
N
-
Rx
Rx
Rx
oral
A04AD12
IVEMEND 115 MG powd for sol for inf
1 viala
10 vial
N
N
Rx
Rx
iv
A04AD12
IVEMEND 150 MG powd for sol for inf
1 viala
10 vial
N
-
Rx
Rx
iv
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT MYLAN 125 MG caps, hard
1 kapsulo blister
10123-731/2018-10
DCP
17-07-2019
14-12-2023
APREPITANT MYLAN 125 MG IN 80 MG caps, hard
1 kapsulo 125 mg aprepitanta in 2 capsma
10123-731/2018-10
DCP
17-07-2019
14-12-2023
APREPITANT MYLAN 80 MG caps, hard
1 kapsulo blister
10123-731/2018-10
DCP
17-07-2019
14-12-2023
APREPITANT SANDOZ 125 MG caps, hard
1 kapsulo (1 x 1 caps blister)
1010-169/2016-16
DCP
14-06-2018
14-06-2023
APREPITANT SANDOZ 125 MG + APREPITANT SANDOZ 80 MG caps, hard
eno 125 mg kapsulo (1 x 1 caps blister)
1010-169/2016-16
DCP
14-06-2018
14-06-2023
APREPITANT SANDOZ 80 MG caps, hard
2 capsma (1 x 2 kapsuli blister)
1010-169/2016-16
DCP
14-06-2018
14-06-2023
APREPITANT TEVA 125 MG IN 80 MG caps, hard
1 pretisnim omotom 1 kapsulo 125 mg apre
1010-55/2017-15
DCP
28-12-2018
28-12-2023
EMEND 125 MG caps, hard
1 caps blister
5 caps pretisnih omotih
EU/1/03/262/004
EU/1/03/262/005
CP
CP
23-04-2012
23-04-2012
EMEND 125 MG , EMEND 80 MG caps, hard
1 caps 125mg in 2 kapsuli 80mg pretisnih
EU/1/03/262/006
CP
23-04-2012
EMEND 80 MG caps, hard
1 caps blister
2 kapsuli blister
5 caps pretisnih omotih
EU/1/03/262/001
EU/1/03/262/002
EU/1/03/262/003
CP
CP
CP
23-04-2012
23-04-2012
23-04-2012
IVEMEND 115 MG powd for sol for inf
1 viala
10 vial
EU/1/07/437/001
EU/1/07/437/002
CP
CP
12-11-2012
12-11-2012
12-11-2012
12-11-2012
12-05-2014
12-05-2014
IVEMEND 150 MG powd for sol for inf
1 viala
10 vial
EU/1/07/437/003
EU/1/07/437/004
CP
CP
23-04-2012
23-04-2012
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
APREPITANT MYLAN 125 MG caps, hard
1 kapsulo blister
APREPITANT MYLAN 125 MG IN 80 MG caps, hard
1 kapsulo 125 mg aprepitanta in 2 capsma
APREPITANT MYLAN 80 MG caps, hard
1 kapsulo blister
APREPITANT SANDOZ 125 MG caps, hard
1 kapsulo (1 x 1 caps blister)
APREPITANT SANDOZ 125 MG + APREPITANT SANDOZ 80 MG caps, hard
eno 125 mg kapsulo (1 x 1 caps blister)
APREPITANT SANDOZ 80 MG caps, hard
2 capsma (1 x 2 kapsuli blister)
APREPITANT TEVA 125 MG IN 80 MG caps, hard
1 pretisnim omotom 1 kapsulo 125 mg apre
24,6
EMEND 125 MG caps, hard
1 caps blister
5 caps pretisnih omotih
EMEND 125 MG , EMEND 80 MG caps, hard
1 caps 125mg in 2 kapsuli 80mg pretisnih
39,81
EMEND 80 MG caps, hard
1 caps blister
2 kapsuli blister
5 caps pretisnih omotih
IVEMEND 115 MG powd for sol for inf
1 viala
10 vial
IVEMEND 150 MG powd for sol for inf
1 viala
10 vial
62,28
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Spain (6)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT ACCORD 125 MG /APREPITANT ACCORD 80 MG caps, hard
1 cap of 125 mg + 2 caps of 80 mg
Y
Rx
oral
A04AD12
APREPITANT SANDOZ 125 MG /APREPITANT SANDOZ 80 MG caps, hard
1 cap of 125 mg y 2 caps of 80 mg
Y
Rx
oral
A04AD12
EMEND 125 MG powd for oral susp
Caja con 1 sobre que contiene polvo para
-
Rx
oral
A04AD12
EMEND 125 MG /EMEND 80 MG caps, hard
(125 mg) 1 cáps + (80 mg) 2 cáps
Y
Rx
oral
A04AD12
FOSAPREPITANT TILLOMED 150 MG powd for sol for inf
1 vial
Y
Rx
iv
A04AD12
IVEMEND 150 MG powd for sol for inf
1 vial
Y
Rx
iv
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT ACCORD 125 MG /APREPITANT ACCORD 80 MG caps, hard
1 cap of 125 mg + 2 caps of 80 mg
84276
20-06-2019
APREPITANT SANDOZ 125 MG /APREPITANT SANDOZ 80 MG caps, hard
1 cap of 125 mg y 2 caps of 80 mg
84781
09-01-2020
EMEND 125 MG powd for oral susp
Caja con 1 sobre que contiene polvo para
103262011
25-02-2016
EMEND 125 MG /EMEND 80 MG caps, hard
(125 mg) 1 cáps + (80 mg) 2 cáps
03262006
02-12-2003
FOSAPREPITANT TILLOMED 150 MG powd for sol for inf
1 vial
84452
09-09-2019
IVEMEND 150 MG powd for sol for inf
1 vial
07437003
04-10-2010
Product
Pack
SPC
PIL
Company
APREPITANT ACCORD 125 MG /APREPITANT ACCORD 80 MG caps, hard
1 cap of 125 mg + 2 caps of 80 mg
APREPITANT SANDOZ 125 MG /APREPITANT SANDOZ 80 MG caps, hard
1 cap of 125 mg y 2 caps of 80 mg
EMEND 125 MG powd for oral susp
Caja con 1 sobre que contiene polvo para
EMEND 125 MG /EMEND 80 MG caps, hard
(125 mg) 1 cáps + (80 mg) 2 cáps
FOSAPREPITANT TILLOMED 150 MG powd for sol for inf
1 vial
IVEMEND 150 MG powd for sol for inf
1 vial
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Sweden (24)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
APREPITANT EBB 125 MG 80 MG caps, hard
Rx
-
A04AD12
APREPITANT MEDICAL VALLEY 125 MG caps, hard
Rx
-
A04AD12
APREPITANT MEDICAL VALLEY 125 MG 80 MG caps, hard
Rx
-
A04AD12
APREPITANT MEDICAL VALLEY 40 MG caps, hard
Rx
-
A04AD12
APREPITANT MEDICAL VALLEY 80 MG caps, hard
Rx
-
A04AD12
APREPITANT SANDOZ 125 MG caps, hard
Rx
-
A04AD12
APREPITANT SANDOZ 125 MG 80 MG caps, hard
Rx
-
A04AD12
APREPITANT SANDOZ 80 MG caps, hard
Rx
-
A04AD12
APREPITANT STADA 125 MG caps, hard
Rx
-
A04AD12
APREPITANT STADA 125 MG 80 MG caps, hard
Rx
-
A04AD12
APREPITANT STADA 80 MG caps, hard
Rx
-
A04AD12
ATANTO 125 MG caps, hard
Rx
-
A04AD12
ATANTO 125 MG 80 MG caps, hard
Rx
-
A04AD12
ATANTO 40 MG caps, hard
Rx
-
A04AD12
ATANTO 80 MG caps, hard
Rx
-
A04AD12
EMEND 165 MG caps, hard
Rx
-
A04AD12
EMEND 125 MG caps, hard
Rx
-
A04AD12
EMEND 125 MG powd for oral susp
Rx
-
A04AD12
EMEND 125 MG 80 MG caps, hard
Rx
-
A04AD12
EMEND 40 MG caps, hard
Rx
-
A04AD12
EMEND 80 MG caps, hard
Rx
-
A04AD12
FOSAPREPITANT ACCORD 150 MG powd for sol for inf
Rx
-
A04AD12
IVEMEND 115 MG powd for sol for inf
Rx
-
A04AD12
IVEMEND 150 MG powd for sol for inf
Rx
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
APREPITANT EBB 125 MG 80 MG caps, hard
PI
13-04-2021
APREPITANT MEDICAL VALLEY 125 MG caps, hard
Nationell decentral eller ömsesidig
25-01-2019
APREPITANT MEDICAL VALLEY 125 MG 80 MG caps, hard
Nationell decentral eller ömsesidig
25-01-2019
APREPITANT MEDICAL VALLEY 40 MG caps, hard
Nationell decentral eller ömsesidig
25-01-2019
APREPITANT MEDICAL VALLEY 80 MG caps, hard
Nationell decentral eller ömsesidig
25-01-2019
APREPITANT SANDOZ 125 MG caps, hard
Nationell decentral eller ömsesidig
02-02-2018
14-01-2021
APREPITANT SANDOZ 125 MG 80 MG caps, hard
Nationell decentral eller ömsesidig
02-02-2018
14-01-2021
APREPITANT SANDOZ 80 MG caps, hard
Nationell decentral eller ömsesidig
02-02-2018
14-01-2021
APREPITANT STADA 125 MG caps, hard
Nationell decentral eller ömsesidig
19-02-2019
APREPITANT STADA 125 MG 80 MG caps, hard
Nationell decentral eller ömsesidig
19-02-2019
APREPITANT STADA 80 MG caps, hard
Nationell decentral eller ömsesidig
19-02-2019
ATANTO 125 MG caps, hard
Nationell decentral eller ömsesidig
25-01-2019
ATANTO 125 MG 80 MG caps, hard
Nationell decentral eller ömsesidig
25-01-2019
ATANTO 40 MG caps, hard
Nationell decentral eller ömsesidig
25-01-2019
ATANTO 80 MG caps, hard
Nationell decentral eller ömsesidig
25-01-2019
EMEND 165 MG caps, hard
CP
28-11-2011
18-06-2020
EMEND 125 MG caps, hard
CP
11-11-2003
EMEND 125 MG powd for oral susp
CP
16-12-2015
EMEND 125 MG 80 MG caps, hard
CP
11-11-2003
EMEND 40 MG caps, hard
CP
29-05-2006
18-06-2020
EMEND 80 MG caps, hard
CP
11-11-2003
FOSAPREPITANT ACCORD 150 MG powd for sol for inf
Nationell decentral eller ömsesidig
25-04-2018
IVEMEND 115 MG powd for sol for inf
CP
14-01-2008
16-01-2013
IVEMEND 150 MG powd for sol for inf
CP
31-08-2010
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Switzerland (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
EMEND 125 MG caps
-
B
-
A04AD12
EMEND 80 MG caps
-
B
-
A04AD12
IVEMEND 150 MG Infusionspräparat
-
B
-
A04AD12
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
EMEND 125 MG caps
56359 2
Hauptzulassung
02-12-2003
01-12-2023
EMEND 80 MG caps
56359 1
Hauptzulassung
02-12-2003
01-12-2023
IVEMEND 150 MG Infusionspräparat
57913 2
Hauptzulassung
03-07-2008
02-07-2023
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.